Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03289858 · ClinicalTrials.gov registry record · Phase 4
Randomized Controlled Trial for Exparel Hip Fracture
A Phase 4 study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Phase 4
- Development phase
- 55
- Enrollment target
NCT03289858 is a Phase 4 study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 55 participants.
The verdict
NCT03289858, a Phase 4 study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 55 participants
- Enrollment target
Study Summary
This is a prospective, randomized study looking at the effect that a long-acting local anesthetic has on pain control in patients having surgery for hip fractures. The investigators are conducting the study to see if that reduces the amount of pain medicine needed after surgery, and if it reduces other medical complications after surgery.
Interventions
- DRUG Exparel
- DRUG Sodium Chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2019-01-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03289858
The ClinicalTrials.gov registry entry for NCT03289858 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exparel is the first listed.
NCT03289858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03289858 about?
NCT03289858 is a clinical study titled "Randomized Controlled Trial for Exparel Hip Fracture". This is a prospective, randomized study looking at the effect that a long-acting local anesthetic has on pain control in patients having surgery for hip fractures. The investigators are conducting the study to see if that reduces the amount of pain medicine needed after surgery, and if it reduces ot...
What is the current status of trial NCT03289858?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 55 participants. The study started on 2017-09-01. Estimated completion is 2019-01-22.
What interventions are being tested in trial NCT03289858?
The interventions under investigation include: Exparel (DRUG), Sodium Chloride (DRUG).
Who is sponsoring clinical trial NCT03289858?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.